Senate Plans FDA User Fee Markup This Week; House Not Far Behind
This article was originally published in The Gray Sheet
Executive Summary
Updated draft user fee reauthorization bills issued last week reflect works in progress as lawmakers aim to reach consensus on FDA reforms.